PRKCG and intervertebral disk degenerative disorder: We describe the mechanisms through β_Man exerts its therapeutic effects in the treatment of IDD, and demonstrate that it inhibits M1 macrophage polarization, improves ECM metabolic dysregulation in NPCs and AFCS, prevents cellular senescence and apoptosis, and identifies its potential downstream target, Prkcg.